Tirzepatide
Also known as: Mounjaro · Zepbound
Tirzepatide is a prescription medication or prescription-only peptide topic. Use this page to understand what it is used for, what side effects to ask about, and how it fits into a clinician-guided plan.
SURMOUNT trials showed 20–22% average weight loss at highest dose — highest of any currently approved weight-loss medication.
What to know before you go deeper
A dual GLP-1 and GIP medication that affects appetite and blood sugar through two hormone pathways. In trials, it generally produced more weight loss than semaglutide.
Approval status: FDA Approved. It still requires the right indication, prescription, and follow-up.
Weight loss, Type 2 diabetes management, Cardiovascular risk reduction.
What evidence applies to my situation, what monitoring is needed, and what safer first steps should I try?
Why People Ask About Tirzepatide
- Weight loss
- Type 2 diabetes management
- Cardiovascular risk reduction
- Obstructive sleep apnea
Questions to Bring Up
Prescription GLP-1/GIP medication with label-based titration and monitoring by a licensed prescriber.
Dosing, sourcing, and suitability questions belong with a licensed clinician who can review your history, labs, medications, and goals.
Known Side Effects
- Nausea
- Diarrhea
- Hair shedding
- Muscle loss
- Injection site reactions
Important Safety Notes
Prescription only
Dual mechanism distinguishes it from semaglutide — generally greater weight loss in head-to-head data
Same contraindications as semaglutide (MEN2, medullary thyroid carcinoma history)
What Is Approved?
FDA-approved for type 2 diabetes (Mounjaro) and chronic weight management (Zepbound). Also approved for obstructive sleep apnea.
Your feedback helps us improve the guide.